In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
2011

Combining Antibiotics Against Drug-Resistant Bacteria

Sample size: 31 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lim Tze-Peng, Tan Thean-Yen, Lee Winnie, Sasikala S., Tan Thuan-Tong, Hsu Li-Yang, Kwa Andrea L.

Primary Institution: Singapore General Hospital

Hypothesis

Can combination therapy effectively combat carbapenem-resistant Acinetobacter baumannii?

Conclusion

Combination therapy may be necessary to effectively treat infections caused by carbapenem-resistant Acinetobacter baumannii.

Supporting Evidence

  • 31 CR-AB isolates were identified, all resistant to multiple antibiotics but susceptible to polymyxin B.
  • Combination therapies showed varying levels of bactericidal activity against different isolates.
  • Polymyxin B plus rifampicin was the most effective combination, killing 41.9% of isolates.

Takeaway

Doctors are trying different combinations of antibiotics to fight a tough germ that doesn't respond to many medicines. Some combinations work better than others.

Methodology

The study collected CR-AB isolates from hospitals, tested their susceptibility to antibiotics, and conducted time-kill studies with various combinations.

Limitations

The study's findings may not be applicable to all strains due to the strain-specific nature of antibiotic resistance.

Participant Demographics

Isolates were collected from five geographically separate hospitals in Singapore.

Digital Object Identifier (DOI)

10.1371/journal.pone.0018485

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication